ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Henlius Licenses Phase 3 Innovative HER2 ADC from GeneQuantum Henlius
August 20, 2025Recently, Shanghai Henlius Biotech, Inc. (2696.HK) has entered into a strategic collaboration with GeneQuantum Healthcare (Suzhou) Co., Ltd. ("GeneQuantum"). -
GeneQuantum announces two key leadership appointments prnasia
September 23, 2021GeneQuantum Healthcare, an industry-leading biotech company dedicated to the next generation bioconjugate drugs based on the innovative intelligent ligase-dependent conjugation (iLDC) technology platform... -
GeneQuantum Raises Hundreds of Millions RMB in Series C Funding prnasia
May 19, 2021GeneQuantum Healthcare (Suzhou) Co., Ltd. announced the completion of Series C fund raising of several hundreds of millions RMB.
Pharma Sources Insight July 2025
